NCT05499624 is a NA clinical trial of MicroTrend System in Hypoperfusion, sponsored by ExoStat Medical, Inc..

Who is sponsoring NCT05499624?

NCT05499624 is sponsored by ExoStat Medical, Inc..

What drugs are being tested in NCT05499624?

Interventions in NCT05499624: MicroTrend System.

What condition does NCT05499624 study?

NCT05499624 studies Hypoperfusion.

Is NCT05499624 still recruiting?

NCT05499624 is currently terminated. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT05499624

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

POMCO2 Clinical Study MicroTrend System pCO2 Sensor

Terminated NA Last updated 10 March 2023

What this trial tests

NA trial testing MicroTrend System in Hypoperfusion in 7 participants. Terminated before completion.

Timeline

22 November 2022

Primary endpoint
9 January 2023

9 January 2023

Quick facts

Lead sponsor	ExoStat Medical, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	7
Start date	22 November 2022
Primary completion	9 January 2023
Estimated completion	9 January 2023
Sites	1 location across United States

Drugs / interventions tested

MicroTrend System

Conditions studied

Hypoperfusion — all drugs for Hypoperfusion →

Sponsor

ExoStat Medical, Inc.

Who can join

22 and older, any sex, with Hypoperfusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this non-significant risk (NSR) study is to evaluate the safety and efficacy of the MicroTrend System by correlating POMCO2 data with relevant clinical metrics including arterial pressure and heart rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoperfusion

Currently open trials in the same condition.

NCT07264543 — Early Methylene Blue in the Microhemodynamics of Septic Patients · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05499624 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ExoStat Medical, Inc.
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing